Biocon announced that the European Directorate for the Quality of Medicines & HealthCare (EDQM) conducted a GMP inspection of an API manufacturing site in Bangalore from the 12 to 14 September 2022 and issued a list of deficiencies on 5 October 2022. There were no critical deficiencies and one deficiency cited under the category 'Major'.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
